NOVA1 disruption was linked to early splicing changes in ALS motor neurons
Original source
Aberrant NOVA1 function disrupts alternative splicing in early stages of amyotrophic lateral sclerosis. (opens in a new tab)Compass summarised this from the study's abstract.
Study details
- Studied in
- Human, Mouse, Cells
Related topics
A study found abnormal alternative splicing and disrupted NOVA1 function in induced pluripotent stem cell-derived motor neurons from people with sporadic and familial amyotrophic lateral sclerosis (ALS). The changes were observed at early stages, including in tissue without TDP-43 pathology, suggesting that NOVA1-related disruption can occur alongside changes involving TDP-43.
Why this matters
The findings identify NOVA1 and RNA splicing as possible early mechanisms in ALS. They come from laboratory-grown motor neurons, mouse experiments and postmortem tissue, so they do not yet change treatment or show that targeting NOVA1 benefits people with ALS.
Limitations and context
This was mechanistic research using induced pluripotent stem cell-derived motor neurons, mouse models and human postmortem tissue, rather than a clinical treatment study. The findings still need to be confirmed in living people and shown to affect disease progression or treatment response.